Clinical Trial Update: Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma

View source ↗

Summary

A longitudinal phenotyping and endotyping study in adults with asthma across severity levels. The sponsor is Hvivo and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Hvivo | Conditions: Asthma (Diagnosis) | Status: RECRUITING